770 related articles for article (PubMed ID: 7589484)
21. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.
Kim HM; Oh GT; Hong DH; Kim MS; Kang JS; Park SM; Han SB
FEBS Lett; 1997 Jul; 412(1):201-6. PubMed ID: 9257720
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
Uchiyama-Kokubu N; Watanabe T
Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
[TBL] [Abstract][Full Text] [Related]
23. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
24. Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells.
Kusaba H; Kohno K; Asakuno K; Kuwano M; Okumura K; Green ED; Schlessinger D; Wada M
Genome Res; 1995 Oct; 5(3):245-58. PubMed ID: 8593612
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
26. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X
J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825
[TBL] [Abstract][Full Text] [Related]
27. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole SP; Sparks KE; Fraser K; Loe DW; Grant CE; Wilson GM; Deeley RG
Cancer Res; 1994 Nov; 54(22):5902-10. PubMed ID: 7954421
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
Knutsen T; Mickley LA; Ried T; Green ED; du Manoir S; Schröck E; Macville M; Ning Y; Robey R; Polymeropoulos M; Torres R; Fojo T
Genes Chromosomes Cancer; 1998 Sep; 23(1):44-54. PubMed ID: 9713996
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of multidrug resistance in feline lymphoma cells.
Okai Y; Nakamura N; Matsushiro H; Kato H; Setoguchi A; Yazawa M; Okuda M; Watari T; Hasegawa A; Tsujimoto H
Am J Vet Res; 2000 Sep; 61(9):1122-7. PubMed ID: 10976746
[TBL] [Abstract][Full Text] [Related]
31. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
Parekh H; Simpkins H
Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
[TBL] [Abstract][Full Text] [Related]
32. Chemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated p-glycoprotein, GST-P and Bcl-2.
Zhu B; Liu GT; Zhao YM; Wu RS; Strada SJ
Cancer Biol Ther; 2006 May; 5(5):536-43. PubMed ID: 16627975
[TBL] [Abstract][Full Text] [Related]
33. Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.
Mizuno K; Furuhashi Y; Maeda O; Iwata M; Misawa T; Kawai M; Kano T; Tomoda Y
Cancer Chemother Pharmacol; 1990; 26(5):333-9. PubMed ID: 1976451
[TBL] [Abstract][Full Text] [Related]
34. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.
Heenan M; O'Driscoll L; Cleary I; Connolly L; Clynes M
Int J Cancer; 1997 May; 71(5):907-15. PubMed ID: 9180164
[TBL] [Abstract][Full Text] [Related]
35. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
36. p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
Hirose M; Kuroda Y
Cancer Lett; 1998 Jul; 129(2):165-71. PubMed ID: 9719458
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
[TBL] [Abstract][Full Text] [Related]
38. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
40. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
Germann UA; Ford PJ; Shlyakhter D; Mason VS; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):141-55. PubMed ID: 9073310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]